Biotech · Private company
Jacobio Pharmaceuticals Co., Ltd.
Track this companyFree. Adds Jacobio Pharmaceuticals Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- CetuximabPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Cetuximab (EGFR inhibitor)Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- JAB-21822 (KRAS G12C inhibitor)Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- JAB-23E73Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- JAB-2485 (Aurora A inhibitor)Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- JAB-30355Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- JAB-3068Phase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- JAB-3312Phase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- JAB-8263Phase 1 · Solid Tumors, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS AlterationPHASE1_PHASE2 · RECRUITING · started May 29, 2025ClinicalTrials.gov NCT06973564 · fetched Nov 12, 2026
- JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C MutationPHASE1_PHASE2 · RECRUITING · started Jul 24, 2024ClinicalTrials.gov NCT06386146 · fetched Nov 12, 2026
- JAB-2485 Activity in Adult Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Dec 20, 2022ClinicalTrials.gov NCT05490472 · fetched Nov 12, 2026
- JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C MutationPHASE1_PHASE2 · COMPLETED · started Sep 3, 2021ClinicalTrials.gov NCT05002270 · fetched Nov 12, 2026
- A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Nov 23, 2020ClinicalTrials.gov NCT04587479 · fetched Nov 12, 2026
- A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 26, 2019ClinicalTrials.gov NCT04045496 · fetched Nov 12, 2026
- A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Apr 23, 2018ClinicalTrials.gov NCT03518554 · fetched Nov 12, 2026